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Introduction
The mitral annulus (MA) separates the left atrium (LA) 
from the left ventricle (LV) and plays an important 
role in promoting LA and LV filling and emptying (1). 
The geometric shape of the MA approximates a hyperbolic 
paraboloid, which can be likened to a saddle (2). Alterations 
in MA size and function could be demonstrated in different 
clinical scenarios including different cardiomyopathies 
and ischaemic heart disease (3,4). Diabetes mellitus is a 
metabolic disease characterized by chronic hyperglycemia 
which causes micro- and macrovascular complications. 
There is a high prevalence of DM among subjects with 
calcific aortic stenosis and MA calcification, as well (5). 
However, it would be important if early changes in MA 
morphology and function could be detected in type 1 
diabetes mellitus (T1DM) before MA calcification occurs. 
Three-dimensional speckle tracking echocardiography 
(3DSTE) is a new clinical tool validated for LA and LV 
chamber quantifications and functional featuring (6,7). 
Moreover, its capability in reproducible assessment 
of MA dimensions al lowing simple calculation of 
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LA ejection force has also been demonstrated (8). 
The present study designed to evaluate MA size and 
functional properties in young T1DM patients by 3DSTE 
and to compare their results to matched healthy controls. 
Patients and methods
Patients population
The study comprised 18 non-obese patients with T1DM 
(mean age: 33.0±8.0 years, 8 males, duration of T1DM: 
17.3±10.2 years, HbA1c: 8.2±1.8%, daily insulin dose: 
37.6±7.1 IU, body mass index: 24.1±2.4 kg/m2) with 
subcutaneous insulin pump-treatment without cardiac 
symptoms. All T1DM patients with such treatment at the 
time of writing of the manuscript were involved into the 
present study from the patient population of the outpatient 
clinic of the diabetology division of the 1st Department of 
Medicine at the University of Szeged, Hungary. Their results 
were compared to 20 age- and gender-matched healthy 
controls (mean age: 37.8±10.9 years, 9 males, body mass 
index: 25.3±1.2 kg/m2). All subjects with known diseases or 
any condition which could affect the results were excluded 
from the control group. Healthy cases were primarily 
recruited on voluntary bases from the student and young 
fellows’ population at our university. All T1DM patients 
and controls had undergone complete two-dimensional 
(2D) Doppler echocardiography and 3DSTE. American 
Diabetes Association (9) and World Health Organization (10) 
criteria were used for definition of T1DM. Systolic or 
diastolic elevation of the blood pressure (>140/90 mmHg) or 
ongoing antihypertensive therapy were used for definition 
of hypertension. A total cholesterol level >5.0 mmol/L or 
current treatment with lipid-lowering medications were 
used for definition of hypercholesterolaemia. Weight and 
height of all subjects were recorded and body surface area 
(BSA) was calculated by the standard formula (weight0.425 in 
kilograms × height0.725 in centimeters ×0.007184). All subjects 
have been included in the MAGYAR-Path Study (Motion 
Analysis of the heart and Great vessels bY three-dimensionAl 
speckle-tRacking echocardiography in Pathological cases) 
(11-13). This has been organized at the Cardiology Center 
of the University of Szeged, Hungary to evaluate clinical 
significance of 3DSTE-derived parameters in pathological 
cases (‘magyar’ means ‘Hungarian’ in Hungarian language). 
The Ethics Committee of the University of Szeged, 
Hungary, approved the study and informed consent was 
obtained from all participants (14).
2D echocardiography
All subjects underwent conventional 2D Doppler 
echocardiography, performed using a commercially 
available ultrasonic device (Toshiba ArtidaTM; Toshiba 
Medical Systems, Tokyo, Japan) with a PST-30SBP 
(1-5 MHz) phased-array transducer. LV diameters and 
volumes and LA diameter were measured in parasternal 
long-axis view and the method of Teichholz et al. was used 
for calculation of ejection fraction (15). Visual grading was 
used for quantification of mitral regurgitation (MR). MA 
diameter (MAD2D) was obtained from an apical 4-chamber 
view at end-diastole (just before mitral valve closure).
3DSTE-derived mitral annular measurements
3DSTE-derived pyramidal datasets were acquired in 
the apical view using a fully sampled PST-25SX matrix-
array transducer (Toshiba Medical Systems, Tokyo, Japan) 
(7,8,11-13,16). The depth and angle were adjusted in order 
to reach optimal temporal and spatial resolution. Full 
volume images were stitched from six subvolumes in six 
consecutive cardiac cycles. Measurements were performed 
using 3D Wall Motion Tracking software version 2.7. The 
apical two-chamber (AP2CH) and four-chamber (AP4CH) 
views and three short-axis views at different LV levels from 
the base to the apex were automatically selected from the 
3D echocardiographic pyramidal dataset at end-diastole 
by the software. The Q7 short axis view was positioned 
at the level of MA in order to calculate morphological 
MA parameters. AP2CH and AP4CH views helped to 
find optimal endpoints of the MA. Measurements were 
made both at end-diastole and end-systole. The following 
measures were obtained (1,3,4,17) (Figure 1): 
(I) M A  d i a m e t e r  ( M A D 3 D) ,  d e f i n e d  a s  t h e 
perpendicular line drawn from the peak of MA 
curvature to the middle of the straight MA border 
both at systole and diastole;
(II) MA diameter index (MADI3D), defined as MAD3D/
BSA;
(III) MA area (MAA3D), measured at end-diastole (just 
before mitral valve closure) and at end-systole (just 
before mitral valve opening);
(IV) MA area index (MAAI3D), defined as MAA3D/BSA;
(V) MA perimeter (MAP3D);
(VI) MA perimeter index (MAPI3D), defined as MAP3D/
BSA;
(VII) MA fractional shortening (MAFS3D), defined as: 
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[(end-diastolic MAD3D—end-systolic MAD3D)/
end-diastolic MAD3D ×100];
(VIII) MA fractional area change (MAFAC3D), defined 
as: [(end-diastolic MAA3D—end-systolic MAA3D)/
end-diastolic MAA3D ×100].
Statistical analysis
Quantitative data were expressed as mean ± standard 
deviation. For all analyses, two-sided P<0.05 was defined 
as statistical significance. An independent-sample t-test was 
utilised for comparison between two groups. Categorical 
variables were compared using chi-square test and Fischer’s 
exact test. Pearson’s coefficient was calculated to examine 
correlations between MAD2D and MAD3D and MA and LV 
functional parameters. Commercially available MedCalc 
software was used for statistical calculations (MedCalc, 
Mariakerke, Belgium). 
Results
Demographic and 2D echocardiographic data
No significant differences could be demonstrated in 
demographic and standard echocardiographic parameters 
between the groups (Table 1). No T1DM patients or healthy 
controls showed significant (≥ grade 1) MR. No calcification 
could be demonstrated in any of T1DM patients. Diastolic 
MAD2D of T1DM patients and controls was 2.70±0.21 cm 
and 2.47±0.26 cm, respectively (P=0.05). Systolic MAD2D 
of T1DM patients and controls was 2.01±0.15 cm and 
2.03±0.18 cm, respectively (P=0.81).
3DSTE-derived MA parameters
Significantly enlarged diastolic MA diameter, MA diameter 
index and MA area index could be demonstrated together 
with augmented MAFS3D in T1DM patients as compared to 
age- and gender matched healthy controls (Table 2). 
Correlations between MAD2D vs. MAD3D
Measurements of MAD2D and MAD3D were well correlated 
both in T1DM patients and controls (r=0.80, P<0.01 and 
r=0.81, P<0.01, respectively). 
MA function and LV function
MAFAC3D did not correlate with LVEF2D in any subjects 
or patients. MAFS3D correlated with LVEF2D in control 
subjects (r=0.50, P=0.03).
Discussion
Morphologic and functional aspects of the MA in young 
patients with T1DM were assessed by 3DSTE in the 
Figure 1 Images from three-dimensional full-volume dataset showing left ventricle (LV) in a patient with type 1 diabetes mellitus (T1DM): (A) 
apical four-chamber view, (B) apical two-chamber view and a cross sectional view at the level of the mitral annulus (MA) (C7) optimalized on 
apical four- and two-chamber views.
A B C
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present work. To the best of authors’ knowledge this is the 
first study in which early alterations in MA size and function 
could be detected in young T1DM patients without MR/
valvular calcifications by 3DSTE. Enlarged diastolic 
MA dimensions and augmented MA function could be 
demonstrated as compared to matched healthy controls. 
S e v e r a l  m e t h o d o l o g i e s  i n c l u d i n g  d i f f e r e n t 
echocardiographic techniques (1,18,19), computer 
tomography (CT) (20) and cardiac magnetic resonance 
imaging (cMRI) (21) could be used for non-invasive 
quantification of MA size and function. Volumetric real-
time 3D echocardiography (RT3DE) and real-time 3D 
transesophageal echocardiography (RT3DTEE) has 
been demonstrated to be useful for non-(semi-)invasive 
estimation of MA morphology and functional properties 
(1,3,4,17,19). 3DSTE seems to be a promising tool 
based on “block-matching” algorithm by strain analysis 
for evaluation of atrial and ventricular volumes, strains, 
rotational and dyssynchrony parameters (7,8,12,13,16). 
In a recent study capability of 3DSTE in reproducible 
assessment of MAD and MAA has also been confirmed (8). 
3DSTE-derived MA parameters, especially MAD however, 
showed somewhat lower values as demonstrated before 
for that of healthy subjects by RT3DE (17). However, in 
other 2D echocardiographic studies, MAA values were in 
Table 1 Baseline demographic and 2D echocardiographic data 
in patients with T1DM and controls
Parameters 
T1DM 
patients 
(n=18)
Controls 
(n=20) 
P value
Risk factors [%]
Age (years) 33.0±8.0 37.8±10.9 0.15
Male gender 8 [44] 9 [45] 1.00
Hypertension 4 [22] 0 [0] 0.04
Diabetes mellitus 18 [100] 0 [0] <0.0001
Hypercholesterolaemia 4 [22] 0 [0] 0.04
2D echocardiography
LA diameter (mm) 33.6±6.6 34.2±2.9 0.74
LV end-diastolic 
diameter (mm)
46.3±5.7 47.7±6.1 0.43
LV end-diastolic volume 
(mL)
100.7±29.1 101.0±19.3 1.00
LV end-systolic diameter 
(mm)
29.4±4.6 30.3±4.1 0.62
LV end-systolic volume 
(mL)
34.4±12.4 35.0±10.9 0.93
Interventricular septum 
(mm)
9.00±1.88 9.46±2.01 0.49
LV posterior wall (mm) 9.04±0.90 9.50±2.35 0.47
LV ejection fraction (%) 65.9±7.9 66.3±6.9 0.94
E/A 1.50±0.49 1.33±0.11 0.10
T1DM, type 1 diabetes mellitus; LA, left atrial; LV, left 
ventricular; 2D, two-dimensional.
Table 2 3DSTE-derived MA morphological and functional 
parameters in with T1DM and controls
Parameters
T1DM 
patients 
(n=18)
Controls 
(n=20)
P value
Diastolic morphological parameters
Diastolic MA diameter 
(cm)
2.87±0.27 2.58±0.32 0.01
Diastolic MA diameter 
index (cm/m2)
1.61±0.20 1.30±0.39 0.008
Diastolic MA area (cm2) 8.61±1.57 7.82±1.83 0.18
Diastolic MA area index 
(cm2/m2)
4.81±0.88 3.91±1.35 0.03
Diastolic MA perimeter 
(cm)
10.76±1.05 10.45±1.19 0.43
Diastolic MA perimeter 
index (cm/m2)
6.02±0.77 5.23±1.44 0.06
Systolic morphological parameters
Systolic MA diameter 
(cm)
2.04±0.26 2.07±0.30 0.74
Systolic MA diameter 
index (cm/m2)
1.14 ±0.15 1.08±0.17 0.37
Systolic MA area (cm2) 4.86±1.17 4.61±0.94 0.49
Systolic MA area index 
(cm2/m2)
2.71±0.60 2.41±0.47 0.12
Systolic MA perimeter 
(cm)
8.18±1.03 7.96±0.85 0.50
Systolic MA perimeter 
index (cm/m2)
4.57±0.62 4.19±0.54 0.06
Systolic functional parameters (%)
MA fractional area 
change 
42.22±15.51 40.06±12.49 0.65
MA fractional shortening 28.64±9.63 20.35±12.50 0.05
T1DM, type 1 diabetes mellitus; MA, mitral annulus; 3DSTE, 
three-dimensional speckle tracking echocardiography.
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the similar range as in the present 3DSTE study (22,23). 
Our results could be explained by 3DSTE-related technical 
limitations including low image quality and temporal 
and spatial resolutions. Moreover, definition of normal 
MA is quite variable, probably caused by the complex 
3D saddle-shaped geometry of the MA, which could give 
an opportunity for inadequate positioning of the cross-
sectional plane on it during measurements (17). These facts 
could lead for underestimation of MA parameters. It should 
also be taken into consideration that mostly young patients 
without any risk factors or other conditions were involved 
into the study. Theoretically there were no reasons for MA 
dilatation or functional alterations in these cases. Results 
could highlight on the importance on additional validation 
of the method which requires serial comparative studies 
with other imaging methodologies. 
In recent studies, despite MA dilatation in patients 
with hypertrophic cardiomyopathy (HCM) and dilated 
cardiomyopathy (DCM), MA function was found to be 
augmented in HCM patients and impaired in DCM patients 
as assessed by RT3DE-derived MAFAC and MAFS (3). 
Similar alterations could be detected in noncompaction 
cardiomyopathy (NCCM): MA dilatation was associated 
with decreased MA functional properties by RT3DE (4). 
It is also known, that calcification within the MA results 
from a degenerative process in the cardiovascular fibrous 
skeleton, which is reported to be accelerated by several 
risk factors including DM (24,25). With the present study, 
MA dilatation and compensating enhancement in MA 
function could be demonstrated in young T1DM patients 
before MA calcification would have been developed. These 
findings could draw our attention on the fact, that valvular 
remodeling starts even in younger ages with compensating 
functional alterations in T1DM. However, further studies 
are warranted to confirm our findings focusing on clinical 
implications. 
Limitation section
The following important limitations should be taken into 
consideration over mentioned above: 
(I) 3DSTE has been demonstrated to be suitable for 
the evaluation of volumetric, strain, rotational 
and dyssynchrony parameters of different heart 
chambers. However, the present study did not aim 
to analyse these parameters;
(II) Higher grade of MR should have affected results. 
However, none of T1DM patients and controls had 
≥ grade 1 MR; 
(III) A limited number of T1DM patients and controls 
were examined and compared in this study. This 
fact should be taken into consideration when 
interpreting results; 
(IV) Patients in non-sinus rhythm would have been 
excluded due to the nature of 3DSTE. However, all 
subjects were in sinus rhythm;
(V) Further validation studies are warranted for the 
usefulness of 3DSTE in the evaluation of valvular 
morphology and functional properties. 
Conclusions
Early alterations in MA size and function could be 
demonstrated in young patients with T1DM by 3DSTE.
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